Caelum Biosciences, Inc.

2 Gansevoort Street
9th Floor
New York
New York
10014
United States

About Caelum Biosciences, Inc.

Caelum was founded by Fortress Biotech in January 2017 to advance the clinical development of research from Alan Solomon, M.D., of the University of Tennessee Graduate School of Medicine, with the goal of improving treatment options for patients with AL amyloidosis.
YEAR FOUNDED:
January 2017
LEADERSHIP:
CEO: Michael Spector
CLINICAL TRIAL:
Please click here for clinical trial information.
FOLLOW CAELUM BIOSCIENCES:
Tweets by Caelum Biosciences

Currently, there are no jobs for this employer on BioSpace.

Browse jobs with BioSpace Featured Employers here.